News
IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated net sales revenue of $25.0 million Company ends Q2 with $238.5 million in cash, cash equivalents and investments Company raises ...
The New Hampshire Department of Environmental Services is calling for an Air Quality Action Day and advising sensitive groups across the state to limit time spent outdoors Tuesday, citing air ...
The Center for Medicare and Medicaid Innovation may introduce a five-year pilot model to expand access to weight loss drugs, ...
The second-quarter earnings season for the drug and biotech sector accelerated last week and will be in full swing this week, ...
Eagles All-Pro RB says he is not joining Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor on President Trump's Council on Sports, Fitness, and Nutrition.” ...
6h
Zacks Investment Research on MSNNovo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?
Novo Nordisk NVO is scheduled to report its second-quarter 2025 results before the opening bell on Aug. 6, 2025. The Zacks ...
Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.
Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss.
President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies ...
More than 160 people working at a Market Basket in New Bedford, Massachusetts, are unauthorized to work in the United States, which led to the suspension of 47 employees, the ...
Trump administration eyes Medicare and Medicaid coverage for weight loss drugs like Wegovy and Ozempic in a five-year pilot ...
Employer insurance premiums are expected to rise in 2026, driven by macro-economic factors and increasing prices and use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results